Neuronal nAChRs in the medial habenula (MHb) to the interpeduncular nucleus (IPN) pathway are key mediators of nicotine's aversive properties. In this paper, we report new details regarding nAChR anatomical localization and function in MHb and IPN. A new group of knock-in mice were created that each expresses a single nAChR subunit fused to GFP, allowing high-resolution mapping. We find that ␣3 and ␤4 nAChR subunit levels are strong throughout the ventral MHb (MHbV). In contrast, ␣6, ␤2, ␤3, and ␣4 subunits are selectively found in some, but not all, areas of MHbV. All subunits were found in both ChAT-positive and ChAT-negative cells in MHbV. Next, we examined functional properties of neurons in the lateral and central part of MHbV (MHbVL and MHbVC) using brain slice patch-clamp recordings. MHbVL neurons were more excitable than MHbVC neurons, and they also responded more strongly to puffs of nicotine. In addition, we studied firing responses of MHbVL and MHbVC neurons in response to bath-applied nicotine. Cells in MHbVL, but not those in MHbVC, increased their firing substantially in response to 1 M nicotine. Additionally, MHbVL neurons from mice that underwent withdrawal from chronic nicotine were less responsive to nicotine application compared with mice withdrawn from chronic saline. Last, we characterized rostral and dorsomedial IPN neurons that receive input from MHbVL axons. Together, our data provide new details regarding neurophysiology and nAChR localization and function in cells within the MHbV.
Introduction
Recently, human genetic studies have uncovered a number of alleles that confer susceptibility to developing dependence to nicotine found in tobacco products . The most striking risk alleles are located within a gene cluster on chromosome 15 containing the ␣3, ␤4, and ␣5 nAChR genes (Saccone et al., , 2009 Bierut et al., 2008) . These nAChR subunits, particularly ␣3 and ␤4, exhibit extremely high expression in both medial habenula (MHb) and interpeduncular nucleus (IPN) (Dineley-Miller and Patrick, 1992; Marks et al., 1992) . Several rodent studies indicate a key role for ␣5-and/or ␤4-containing nAChRs in modulating nicotine intake. For example, ␣5 KO mice consume significantly more nicotine than their ␣5 WT counterparts, and reexpression of ␣5 subunits in MHb of ␣5 KO mice restores aversion to high doses of nicotine (Fowler et al., 2011) . In a complementary study, Frahm et al. (2011) found that overexpression of ␤4-containing nAChRs in MHb enhances aversion to, and consequently reduces consumption of, nicotine. These studies, coupled with recent findings indicating the existence of distinct neuronal populations in ventral MHb (MHbV) (Aizawa et al., 2012) , point to the need for a better understanding of nAChR function within specific cell populations in MHbV.
Several nAChR subunits exhibit their highest expression level in the MHb (Perry et al., 2002) . In addition, most nAChR subunits found in heteromeric receptors are expressed in MHb (Dineley-Miller and Patrick, 1992; Marks et al., 1992) , which theoretically increases the number of distinct nAChR subtypes found in MHb compared with other brain areas. Several studies have attempted to identify important nAChR subtypes in MHb neurons. Robin Lester and colleagues identified ␣3␤4* (* ϭ subunits in addition to those listed may be found in the indicated pentameric receptor) nAChRs as the predominant subtype in MHbV, with a minor contribution from ␤2* nAChRs in some cells (Quick et al., 1999) . Studies in mice expressing gain-offunction ␣4 nAChR subunits demonstrated expression and function of ␣4* nAChRs in lateral MHbV neurons Fonck et al., 2009) .
Because of the small size of the MHb, prior studies using radioligand binding or mRNA in situ hybridization did not allow for high-resolution mapping of nAChR subunit localization in specific cell types within this brain area. Although basic electrophysiological features of MHb neurons are starting to be uncov-ered (Kim and Chang, 2005) , we fail to understand how activation of MHb nAChRs changes excitability of the neurons in which they reside and the circuits into which they are integrated. To address these shortcomings in our understanding of MHb nAChR function, we combined immunohistochemistry with brain slice patch-clamp electrophysiology using mouse models. We generated knock-in mouse strains expressing ␣3, ␣4, ␤2, ␤3, and ␤4 nAChR subunits fused to GFP. Along with previously generated ␣6-GFP mice (Mackey et al., 2012) , we localized six nAChR subunits in specific regions of MHb and IPN. Further, in recordings from MHb and IPN neurons in brain slices from C57BL/6 WT mice, we identified neuronal cell types that differ in their sensitivity to nicotine.
Materials and Methods
Materials. CNQX and picrotoxin were purchased from Tocris Bioscience, and all other drugs and chemicals not indicated above were purchased from Sigma-Aldrich.
Mice. C57BL/6 mice used for electrophysiology studies were purchased from The Jackson Laboratory. Bacterial artificial chromosome (BAC) transgenic mice expressing GFP-labeled ␣6 nAChR subunits were described previously (Mackey et al., 2012) . Briefly, a BAC containing the ␣6 nAChR subunit gene was modified by recombineering to introduce a GFP sequence in-frame into the M3-M4 portion of the ␣6 open reading frame. This modified BAC was used to produce transgenic mice. In these mice, ␣6 nAChRs exhibit normal distribution in the brain, normal expression levels, and normal function (Mackey et al., 2012; Henderson et al., 2014) . All groups of mice used in this study had approximately equal numbers of males and females. All mice were between 8 and 14 weeks old when experiments were conducted.
Construction and testing of GFP-labeled ␣3 and ␤4 nAChR subunits. Mouse ␣3 and ␤4 nAChR cDNAs in pCDNA3.1 were a generous gift from Jerry Stitzel (Institute for Behavioral Genetics, University of Colorado, Boulder, CO). GFP was inserted in-frame into the M3-M4 loop region of the ␣3 and ␤4 nAChR subunit coding sequence. This insertion site yields normal, functional receptors when GFP (or similar fluorophore such as YFP or CFP) is inserted into ␣4 (Nashmi et al., 2003 , ␣6 (Drenan et al., 2008a; Mackey et al., 2012) , ␤2 (Nashmi et al., 2003) , and ␤3 (Drenan et al., 2008a) nAChR subunits. GFP insertion was executed using a modified, two-step QuikChange (Stratagene) reaction according to our previously published methods (Drenan et al., 2008a) . Briefly, an Ala-Gly-Ala linker was inserted immediately 5Ј and 3Ј to the GFP coding sequence. AlaGlyAla-GFP-AlaGlyAla was inserted between residues Gly373 and Ala374 in mouse ␣3 and between residues Gly378 and Pro379 in mouse ␤4. All DNA constructs were fully sequenced before use.
To verify that GFP-labeled ␣3 and ␤4 nAChR subunits were functional, two-electrode voltage clamp in Xenopus laevis oocytes was conducted as previously described for other GFP-labeled nAChR subunits (Drenan et al., 2008a) . Briefly, constructs were linearized and cRNA was produced using a T7 in vitro transcription kit (mMessage mMachine; Ambion). RNA yield was quantified with absorbance at 260 nm. Highquality WT or GFP ␣3:␤4 cRNA was injected at a ratio of 2:3 by mass into stage V to VI X. laevis oocytes. After injection, oocytes were incubated for 1-4 d in ND-96 buffer (in mM: 96 NaCl, 2 KCl, 1 CaCl 2 , 1 MgCl 2 , and 5 HEPES/NaOH, pH 7.6) supplemented with 50 g/ml gentamycin and 2.5 mM sodium pyruvate. Two-electrode voltage clamp was performed using an OpusXpress 6000A (Molecular Devices). Oocytes were clamped at a holding potential of Ϫ60 mV; 1 ml of ND-96 solution containing ACh (concentrations indicated in Fig. 1A ) was applied to clamped oocytes for 12 s followed by a 2 min wash with drug-free ND-96. Data were sampled at 50 Hz and filtered at 20 Hz.
nAChR-GFP knock-in mice. Five additional knock-in mouse strains were generated and studied in this project, as summarized in Figure 1 . These nAChR-GFP subunits were designed to insert a monomeric enhanced GFP (called here simply GFP) in-frame into the M3-M4 intracellular loop. The ␣4-GFP knock-in strain was constructed, bred, and backcrossed to C57BL/6 at Caltech (4 generations) using procedures previously used to generate mice with yellow fluorescent protein (YFP)-tagged ␣4 subunits . Four strains were produced by genOway for the ␣3, ␤2, ␤3, and ␤4 nAChR subunits. The exact insertion site of GFP in the nAChR open reading frame of ␣4-GFP, ␤2-GFP, and ␤3-GFP mice was previously described (Nashmi et al., 2003 Drenan et al., 2008a; Srinivasan et al., 2011) . nAChR exon/intron structure is relatively conserved for the genes under study in this paper, and the coding sequence for the M3-M4 loop is contained within exon 5 of the nAChR genes we manipulated. For each nAChR gene, a targeting vector was constructed containing exon 5 with GFP fused in-frame in the desired position in the M3-M4 loop coding sequence. Several kilobases of 5Ј and 3Ј sequence (relative to exon 5) were included to direct homologous recombination. A neomycin cassette flanked by loxP sites was inserted adjacent to the modified exon 5 in the targeting vector. A diphtheria toxin negative selection cassette was inserted adjacent to one of the homology arms (5Ј or 3Ј).
Targeting vectors were linearized and electroporated into C57BL/6 embryonic stem cells. G418-resistant cell clones were isolated and amplified. First, clones were screened via PCR to identify those positive for both the 5Ј and 3Ј homologous recombination events. Next, clones positive in the 5Ј and 3Ј PCR assays were further evaluated for correct homologous recombination (and the absence of additional genomic rearrangements) via Southern blot with probes designed to detect both the 5Ј and 3Ј homologous recombination events. At least three positive ES cell clones were injected into 3.5-d-old embryos (blastocyst stage) derived from an albino C57BL/6 strain (C57BL/6J-Tyr c-2J /J), and reimplanted into pseudo-pregnant females and allowed to develop to term. Progeny males with evidence of high (Ͼ50%) chimerism (based on black vs white coat color) were selected for further breeding after reaching sexual maturity. To both (1) breed chimeras to the F1 generation and (2) excise the neomycin selection cassette from the genome of the F1 progeny, chimeric males were mated with female C57BL/6 Cre-deleter (proprietary to genOway) mice. To confirm germline transmission, neoexcision, and maintenance of the proper homologous recombination event, F1 mice were genotyped via both PCR and Southern blot. Summarizing, all nAChR subunit GFP mice are extensively backcrossed to C57BL/6 (␣6-GFP, ␣4-GFP) or are fully isogenic with C57BL/6 (␤3-GFP, ␤2-GFP, ␤3-GFP, and ␤4-GFP). DNA sequences for all targeting vectors, Southern blotting probes, and PCR primers are available upon request.
Chronic nicotine treatment. To treat mice chronically with nicotine and to study nicotine withdrawal, mice were implanted with primed osmotic minipumps (model 2004; Alzet) filled with sterile saline or (Ϫ)-nicotine hydrogen-tartrate salt dissolved in sterile saline. Nicotine (free base) was delivered at a rate of 1 mg/kg/h for 14 d. On day 14, minipumps were surgically removed, and mice were killed 18 -24 h later for electrophysiology experiments. Alternatively, on day 14 after implantation, some mice were injected intrapertoneally with mecamylamine (1 mg/kg) to precipitate withdrawal. Mice were transcardially perfused 90 min after mecamylamine injection, brains were removed, sectioned (50 m thickness), and stained with anti-c-Fos antibodies as described below.
Immunohistochemistry. For analysis of nAChR-GFP expression in mouse brain, mice under deep anesthesia were perfused transcardially with cold PBS followed by cold PBS containing 4% PFA. Brains were postfixed overnight in 4% PFA in PBS. Using MultiBrain Technology (NeuroScience Associates), nAChR-GFP brains were embedded in a gelatin matrix. After freezing the brain samples to Ϫ70°C with dry ice, they were sliced coronally into 35-m-thick serial sections using a microtome. For anti-GFP staining, the following procedures were followed. Sections were washed 3 times for 5 min per wash in TBS, followed by incubation in peroxide solution (0.9% H 2 O 2 in TBST, which is TBS containing 0.3% Triton X-100) for 30 min. Sections were rinsed 3 times for 5 min per wash in TBS, followed by incubation in blocking serum (normal horse serum diluted 80ϫ into TBST) for 60 min. Sections were rinsed 3 times for 5 min per wash in TBS, followed by incubation in primary antibody solution (rabbit anti-GFP; 1:5000; Millipore) overnight at room temperature. Sections were washed 3 times for 5 min per wash in TBS, followed by incubation in solution containing biotinylated secondary antibodies (goat anti-rabbit biotinylated IgG; 1:240; Vector Laboratories) for 60 min. Sections were washed 3 times for 5 min per wash in TBS, followed by incubation in ABC solution (TBST containing Reagent A and B solutions, VECTASTAIN Elite ABC System; Vector Laboratories) for 120 min. Sections were washed 3 times for 5 min per wash, followed by incubation for 0 -10 min in DAB-H 2 O 2 solution (0.00017% DAB diluted into TBST containing 0.0015% H 2 O 2 ) with continuous visual monitoring of DAB staining. Sections were washed 2 times for 5 min per wash, placed in fresh TBS, mounted onto glass slides, and coverslipped.
Some sections cut by NeuroScience Associates were stained at Purdue and imaged with confocal microscopy. For those, as well as c-Fos stain- Figure 1 . Production of GFP-labeled nAChR subunits. A, Functional characterization of ␣3-GFP and ␤4-GFP subunits. mRNA encoding WT or GFP-fused mouse ␣3 and ␤4 nAChR subunits was transcribed and microinjected (ratio of 2 ␣ subunits:3 ␤ subunits) into X. laevis oocytes. Using two-electrode voltage clamp (holding potential ϭϪ60 mV), inward current responses were recorded during application of ACh at the indicated concentrations. Concentration-response curves were constructed, and data were fitted to the Hill equation. The number of oocytes analyzed was 11 (WT ␣3␤4), 11 (␣3GFP ␤4), and 7 (␣3 ␤4GFP). B, The nAChR genes modified and/or reported on in this study are the following: ␣3, ␣4, ␣6, ␤2, ␤3, and ␤4. For each of these genes, the M3-M4 intracellular loop is the site for insertion of monomeric GFP (abbreviated simply as "GFP") and is encoded by exon 5. Except for the ␣6-GFP strain, for each of these nAChR subunit genes, a targeting vector was built that contained a modified (GFP inserted in-frame) exon 5, a neomycin selection cassette flanked by loxP sites, several kilobases of homologous 5Ј and 3Ј sequence (homology arms), and a diphtheria toxin-negative selection cassette. Targeting vectors were linearized and electroporated into mouse embryonic stem cells. GFP insertion into exon 5 was verified as described in Materials and Methods, targeted ES cell clones were injected into blastocysts, and blastocysts were implanted into pseudopregnant surrogates. Chimeric mice were crossed to Cre-deleter mice to remove the neomycin selection cassette in vivo, and correct gene targeting in neo-excised, F1 progeny was analyzed and verified. Figure 2 . Localization of GFP-fused nAChR subunits in mouse brain. A, Brain atlas diagram for five bregma coordinates (bregma 2 mm, 1 mm, Ϫ1 mm, Ϫ3 mm, Ϫ4 mm) corresponding to approximate bregma coordinates for data presented in B-E. B-E, Brains from six mouse strains expressing GFP-fused nAChR subunits were fixed, sectioned at 35 M, and stained with anti-GFP antibodies. B, C57BL/6 WT brains were processed as a staining negative control. A representative (of n ϭ 3) image of a coronal section is shown for each nAChR-GFP mouse strain at the indicated anterior/posterior coordinate. ␣4 and ␤2 (C), ␣3 and ␤4 (D), and ␣6 and ␤3 (E) were grouped together based on their coexpression in several brain areas.
ing, the following procedures were followed. Sections were collected into 12-well tissue culture plates, washed 3 times for 10 min per wash in TBS, and blocked for 30 min in TBST containing 10% normal horse serum. Sections were washed 3 times for 10 min per wash and incubated in a solution containing TBST and primary antibodies (rabbit anti-GFP; 1:500; Invitrogen; rabbit anti-c-Fos; 1:400; Santa Cruz Biotechnology; and goat anti-ChAT; 1:100; Millipore) overnight at 4°C. Sections were washed 3 times for 10 min per wash in TBST and incubated in a solution containing secondary antibodies (chicken anti-rabbit Alexa-488; 1:500; Invitrogen; and/or donkey anti-goat Alexa-555; 1:500; Invitrogen) for 1-2 h at room temperature. Sections were then rinsed 3 times for 10 min per rinse, mounted onto glass slides, and coverslipped for confocal microscopy.
To test for colocalization of recorded neurons with ChAT, brain slices with neurobiotinfilled neurons were fixed overnight in 4% PFA in PBS and processed essentially as described above for confocal microscopy but with the following modifications. Sections were washed 2 times for 10 min per wash in PBS, blocked, and permeabilized in PBS containing 10% normal horse serum, 2% BSA and 0.3% Triton X-100 (PBST) for 60 min. Sections were incubated with PBST solutions containing primary antibody (goat anti-ChAT; 1:500; Millipore and streptavidin conjugated Alexa-488; 1:1000; Invitrogen) overnight at 4°C. Sections were washed 3 times for 5 min per wash with PBS, followed by incubation in PBST solutions containing secondary antibodies (Alexa-555 donkey-anti-goat; 1:500; Invitrogen) for 120 min at room temperature. Finally, sections were washed 3 times for 10 min per wash with PBS, mounted with anti-fade mounting medium (Vectashield; Vector Laboratories), and coverslipped.
Brain slice preparation for electrophysiology. Two-to 3-month-old C57BL/6J mice (The Jackson Laboratory) and ␣4 knock-out (KO) mice of either sex were used in accordance with the guidelines of the National Institutes of Health Office of Laboratory Animal Welfare, and the protocols were approved by the Institutional Animal Care and Use Committee at Purdue University. Mice were anesthetized by intraperitoneal injection of a sodium pentobarbital (200 mg/kg), followed by transcardiac perfusion with oxygenated (95% O 2 /5% CO 2 ) N-methyl-D-glucamine (NMDG) recovery solution (in mM: 93 NMDG, 2.5 KCl, 1.2 NaH 2 PO 4 , 30 NaHCO 3 , 20 HEPES, 25 glucose, 5 Na ϩ ascorbate, 2 thiourea, 3 Na ϩ pyruvate, 10 MgSO 4 ⅐ 7H 2 O, 0.5 CaCl 2 ⅐ 2H 2 O, with pH adjusted to 7.3-7.4, 300 -310 mOsm). The brain was quickly removed into ice-cold NMDG recovery solution for 1 min, and 200-m-thick coronal slices containing MHb or IPN were cut with a vibrating microslicer (DTKZero 1; Ted Pella). Coordinates were as follows: (MHb: Ϫ1.9 anterior/ posterior, 0.25 lateral, Ϫ2.5 dorsal/ventral; IPN: Ϫ3.5 anterior/posterior, 0.0 lateral, Ϫ4.5 dorsal/ventral). Slices were then incubated in this solution at 33°C for 12 min, after which they were kept at room temperature for at least 1 h in 95% O 2 /5% CO 2 -equilibrated HEPES-holding-solution containing the following (in mM): NaCl 92, KCl 2.5, NaH 2 PO 4 1.2, NaHCO 3 30, HEPES 20, glucose 25, Na ϩ ascorbate 5, thiourea 2, Na ϩ pyruvate 3, MgSO 4 ⅐ 7H 2 O 2, and CaCl 2 ⅐ 2H 2 O 2. Patch-clamp electrophysiology. Recordings were made under an upright microscope (Nikon Eclipse FN-1) equipped with infrared differential interference contrast optics for visualization. Slices were transferred to a recording chamber superfused with standard recording ACSF containing (in mM) NaCl 124, KCl 2.5, NaH 2 PO 4 1.2, NaHCO 3 24, glucose 12.5, MgSO 4 ⅐ 7H 2 O 2, and CaCl 2 ⅐ 2H 2 O 2, adjusted to pH 7.3-7.4, 300 -310 mOsm. Recordings were performed at 32°C. Patch pipettes were made from borosilicate glass capillary tubing (1B150F-4; World Precision Instruments) using a micropipette puller (P-97; Sutter Instrument). The internal recording pipette solution contained the following (in mM): K ϩ gluconate 135, EGTA 5, HEPES 10, MgATP 2, NaGTP 0.1, CaCl 2 0.5, MgCl 2 2; pH adjusted to 7.3 with Tris base. In a subset of experiments, 2.5 mg/ml neurobiotin (Vector Laboratories) was added to the internal solution for intracellular labeling of recorded neurons, and the pH was readjusted. Currents were recorded using a Multiclamp 700B or an Axopatch 200B amplifier with a DigiData 1440A interface and Clampex 10.3 software (Molecular Devices) sampled at 5 kHz and low-pass filtered at 1 kHz. Series resistance was uncompensated.
For some drug applications, CNQX (10 M), picrotoxin (100 M), and atropine (1 M) were added to the superfusion ACSF by dilution of a stock solution. Functional AMPAR and nAChR responses were examined as previously described (Engle et al., , 2013 . Briefly, a drugfilled glass pipette, identical to a typical recording pipette, was connected to a micropressure ejection system (PV-820 Pneumatic PicoPump; World Precision Instruments). Ejection pipettes were moved to within 20 -40 m of the recorded cell using a piezoelectric manipulator (PA-100/12; Piezosystem Jena), drug was applied for 250 ms (12 psi), and the ejection pipette was retracted.
Statistics and data analysis. Summary data are presented in the text and figures as the mean Ϯ SEM t tests (unpaired or paired, as indicated in figure legends) were used for all comparisons. All statistical tests were performed using Graphpad software (Prism). Concentration-response data were fitted to the Hill equation. Differences were considered significant at p Ͻ 0.05.
Results
We previously verified that XFP-tagged ␣4 (Nashmi et al., 2003 . Localization of GFP-fused nAChR subunits in MHb. A, Brain atlas diagram for three bregma coordinates (bregma Ϫ1 mm, Ϫ1.5 mm, and Ϫ2 mm) corresponding to anterior, medial, and posterior MHb (orange). B-E, Brains from six mouse strains expressing GFP-fused nAChR subunits were fixed, sectioned at 35 M, and immunostained with anti-GFP antibodies. B, C57BL/6 WT brains were processed as a staining negative control. A representative (of n ϭ 3) image of an MHb coronal section is shown for each nAChR-GFP mouse strain at the indicated anterior/posterior coordinate. ␣4 and ␤2 (C), ␣3 and ␤4 (D), and ␣6 and ␤3 (E) were grouped together based on coexpression in MHb and/or other brain areas.
some cases, but we have not previously demonstrated the same for ␣3-GFP and ␤4-GFP subunits. To verify that these latter subunits are indeed functional, mRNA for ␣3-GFP and ␤4-GFP nAChR subunits was transcribed and microinjected into X. laevis oocytes. To mimic expression of these GFP-labeled subunits in the knock-in mice, ␣3-GFP was expressed with WT ␤4 subunits, and ␤4-GFP was expressed with WT ␣3 subunits. WT ␣3␤4 receptor function was compared as a reference. ACh was applied to voltage-clamped oocytes for 1 s, and peak current responses were measured. Mean data (Ϯ SEM) were plotted and fitted to the Hill equation for WT ␣3␤4, ␣3-GFP␤4, and ␣3␤4-GFP nAChRs. Both ␣3-GFP and ␤4-GFP subunits supported relatively normal nAChR function compared with WT ␣3␤4 nAChRs (Fig. 1A) . ␣3-GFP␤4 and ␣3␤4-GFP nAChRs had ACh EC 50 values of 92 M (95% confidence interval: 81-105 M) and 262 M (95% confidence interval: 246 -279 M) and Hill coefficients of 1.6 Ϯ 0.1 and 1.8 Ϯ 0.1, respectively. Reference WT ␣3␤4 nAChRs had an ACh EC 50 value of 125 M (95% confidence interval: 113-137 M) and a Hill coefficient of 1.6 Ϯ 0.1, consistent with previous studies on this receptor (Fig. 1A) (Drenan et al., 2008a) . We seek to make exon-replacement knock-in mice with a particular nAChR-GFP mutation only when the mutation is expected to result in a change in sensitivity of approximately twofold or less compared with the WT subunit. Although ␣3␤4-GFP nAChRs did exhibit a slight reduction in sensitivity compared with WT ␣3␤4 nAChRs in oocyte experiments (Fig. 1A) , the change was approximately twofold in magnitude, so we proceeded with this GFP insertion to make ␤4-GFP mice.
For each of the ␣3, ␣4, ␤2, ␤3, and ␤4 nAChR genes, an exon replacement strategy in embryonic stem cells was used to insert an enhanced GFP sequence inframe into exon 5 of the nAChR gene (Fig.  1B) . This resulted in production of nAChR subunits with an intervening, functional GFP protein within the large, M3-M4 intracellular loop. In addition to these 5 new knock-in mouse strains, we also used BAC transgenic mice expressing GFP-fused ␣6 nAChR subunits, which have been reported previously (Mackey et al., 2012) . nAChR-GFP mice were perfused and coronal sections were cut at 35 M from bregma 2 mm to Ϫ4 mm ( Fig.  2A ). Sections were stained with anti-GFP antibodies and visualized with DAB histochemistry. Figure 2B -E shows representative images of GFP-stained coronal sections for all GFP mice (and C57BL/6 WT control mice; Fig. 2B ) at 5 different anterior/posterior coordinates (bregma 2, 1, Ϫ1, Ϫ3, and Ϫ4 mm) corresponding to sites of known expression for these subunits. Subunits were grouped based on similar localization patterns in the brain: ␣4 and ␤2 (Fig. 2C ), ␣3 and ␤4 (Fig. 2D) , and ␣6 and ␤3 (Fig. 2E ). Based on known localization patterns using methods, such as radioligand binding and mRNA in situ hybridization, no aberrant localization of GFP-labeled subunits was apparent in our staining results ( Fig.  2B-E ). ␣4 and ␤2 subunits were distributed throughout the brain, including but not limited to cerebral cortex, striatum, thalamus (including dorsal lateral geniculate nucleus), MHb, substantia nigra (SN), ventral tegmental area (VTA), and superior colliculus (SC) (Fig. 2C ). ␣3 and ␤4 distribution was apparent in piriform cortex, MHb, fasciculus retroflexus (FR), and IPN, with additional ␣3 found apparent in SC (Fig. 2D) . ␣6 was found at low levels in prefrontal cortex and striatum, MHb, SN, VTA, and SC (Fig. 2E) . ␤3, which has been difficult to localize in the brain because it does not participate in a nAChR agonist binding site (Drenan et al., 2008a) , has moderate levels in cortical areas, ST, MHb, FR, SN, VTA, and SC (Fig. 2E) .
To analyze nAChR localization in the MHb to IPN pathway, sections containing MHb (bregma Ϫ1 to Ϫ2 mm; Fig. 3A ) and IPN (bregma Ϫ3.2 to Ϫ3.9 mm; Fig. 4A ) were stained with anti-GFP primary antibodies and peroxidase-conjugated secondary antibodies, followed by visualization with a DAB reaction. Terminology for MHb subnuclei follows a recent study (Aizawa et al., 2012) . ␣4, ␤2, and ␤4 nAChR subunits are restricted to the ventral two-thirds of the MHb (referred to as MHbV) (Fig.  3C,D) . ␣3, ␣6, and ␤3 subunits are also largely restricted to the .5 mm, and Ϫ3.9 mm) corresponding to anterior, medial, and posterior interpeduncular nucleus. B-E, Brains from six mouse strains expressing GFP-fused nAChR subunits were fixed, sectioned at 35 M, and immunostained with anti-GFP antibodies. B, C57BL/6 WT brains were processed as a staining negative control. A representative (of n ϭ 3) image of an IPN coronal section is shown for each nAChR-GFP mouse strain at the indicated anterior/posterior coordinate. ␣4 and ␤2 (C), ␣3 and ␤4 (D), and ␣6 and ␤3 (E) were grouped together based on coexpression in MHb and/or other brain areas.
MHbV, but immunoreactivity for these subunits is also evident in a small number of cells in the dorsal one-third of MHb (MHbD) (Fig. 3 D, E) . ␣3 and ␤4 subunit localization is even and strong throughout the MHbV, with subunits also evident in efferent fibers that give rise to the FR (Fig.  3D) . ␣4 subunits are exclusively found in the lateral portion of the MHbV (referred to as MHbVL) (Fig. 3C) , consistent with previous reports Fonck et al., 2009) . In contrast to ␣4, ␣6 subunits are mainly found in the inferior portion of MHbV (MHbVI), with additional faint expression in the lateral portion of MHbD (Fig. 3E) . ␤2 subunit immunoreactivity is seen throughout MHbV, with preference for central and inferior MHbV (Fig. 3C) . ␤3 subunits are strong in MHbVI and MHbVC but very weak in MHbVL (Fig. 3E) .
Next, nAChR subunit localization was analyzed in IPN from bregma Ϫ3.2 to Ϫ3.9 mm (Fig. 4A ) using anti-GFP immunohistochemistry in C57BL/6 WT ( Fig. 4B ) and nAChR-GFP knock-in mice ( Fig. 4C-E) . Terminology used for IPN subnuclei is consistent with Wada et al. (1989) (Fig. 4D) . ␣4 subunits are strongest in IPR and IPDM, with lower levels of immunoreactivity evident in IPC and IPI (Fig. 4C) . In contrast to ␣4, ␣6 subunits are found at low levels in ventral IPR and IPC with little to no ␣6 subunits found in dorsal IPR or IPDM (Fig. 4E) . ␤2 subunit levels are modest throughout the rostral IPN but are restricted to IPC and IPI in caudal IPN (Fig. 4C) . ␤3 levels are strong in most IPN subnuclei but were not found in dorsal IPR and/or IPDM (Fig. 4E) .
The MHbV stains positive for cholinergic markers, such as ChAT and VAChT (Contestabile et al., 1987) , and IPN nAChRs in presynaptic terminals from MHbV neurons are involved in ACh release ). However, other reports indicate that MHbV neurons are glutamatergic and that nAChRs in presynaptic terminals in IPN are involved in regulating glutamate release (Ren et al., 2011; Hu et al., 2012) . Using mouse strains expressing GFP-labeled nAChRs, we costained brain sections containing MHb with anti-GFP and anti-ChAT primary antibodies. The MHb was imaged at 60ϫ magnification using confocal microscopy. Anti-GFP staining recapitulated our DAB staining results with respect to anatomical specificity; ␣3 and ␤4 subunits were found throughout the MHbV, ␣4 was restricted to MHbVL, ␣6 was largely restricted to MHbVI plus the MHbDC, and ␤2 and ␤3 subunits were found in MHbVI and MHbVC (Fig. 5A) . All subunits were found in some/many ChAT(ϩ) MHbV neurons, but we also found evidence for ␣3, ␣4, and ␣6 subunits localized to ChAT(Ϫ) cells (Fig. 5A) . In contrast, nearly all cells that were immunoreactive for ␤2, ␤3, and ␤4 subunits were also ChAT(ϩ) (Fig. 5B) .
We were interested to further explore the possibility that ChAT(Ϫ) cells contained functional nAChRs, so we studied MHbV neurons and nAChR function using patch-clamp electrophysiology in brain slices from C57BL/6 mice. First, we devel- Figure 5 . nAChR MHb localization and function in ChAT(ϩ) and ChAT(Ϫ) cells. A, For ␣3-GFP, ␣4-GFP, and ␣6-GFP mouse strains, coronal MHb sections were prepared, double-stained with anti-GFP and anti-ChAT antibodies, and imaged using confocal microscopy. Merged (green represents anti-GFP; red represents anti-ChAT; yellow represents colocalized pixels) micrographs of the MHb (top panels), and a high-resolution zoom of several cells in MHb (bottom panels) are shown. Single, diagonal arrowheads indicate cells expressing both ChAT and the nAChR-GFP subunit. Double, horizontal arrowheads indicate cells expressing nAChR-GFP subunits but not ChAT. Scale bars: top, 50 m; bottom, 10 m. B, For ␤2-GFP, ␤3-GFP, and ␤4-GFP mouse strains, coronal MHb sections were prepared, double-stained with anti-GFP and anti-ChAT antibodies, and imaged using confocal microscopy. Merged (green represents anti-GFP; red represents anti-ChAT; yellow represents colocalized pixels) micrographs of the MHb (top panels), and a high-resolution zoom of several cells in MHb (bottom panels) are shown. Single, diagonal arrowheads indicate cells expressing both ChAT and the nAChR-GFP subunit. Double, horizontal arrowheads indicate cells expressing nAChR-GFP subunits but not ChAT. Scale bars: top, 50 m; bottom, 10 m. C, Action potential firing patterns in MHb versus LHb neurons. Coronal habenular brain slices were prepared from C57BL/6 WT mice, and cell-attached recordings were made from MHb and LHb neurons. A representative trace is shown from a typical cell-attached recording from a MHb and LHb neuron. D, In whole-cell configuration, action potential firing in response to hyperpolarizing current (Ϫ50 pA) injections was recorded in MHb and LHb neurons. Representative traces show the latency to recovery of action potential firing, as well as the action potential firing frequency, after cessation of current injection. E, Responses to nicotine puffs in ChAT(ϩ) and ChAT(Ϫ) MHb neurons. MHb neurons were voltageclamped at Ϫ60 mV, and nicotine (30 M, 250 ms) was puff-applied to the cell using a Picopump. Representative inward current deflections are shown for applications of nicotine at the indicated concentration. Responses from ChAT(ϩ) and ChAT(Ϫ) neurons are shown. ChAT expression was later determined and assigned to each cell with a nicotine puff response as described in F. F, ChAT expression in MHb cells. For cells studied in E, neurobiotin was included in the patch pipette internal solution to mark the recorded cell. After successful nicotine puff experiments, neurobiotin-filled cells in slices were recovered and double-stained with streptavidin-Alexa-488 conjugates and anti-ChAT antibodies. A representative ChAT(ϩ) and ChAT(Ϫ) MHb neuron that was studied with nicotine puffs is shown. The wide micrograph shows the location of the cell in the MHb. Inset shows whether the cell was ChAT (ϩ) (yellow color) or ChAT (Ϫ) (green color). Scale bars: 50 m; inset, 10 m.
oped the ability to distinguish MHb neurons from neurons in the adjacent lateral Hb (LHb). Whereas MHb neurons exhibited regular, tonic firing when action potentials were recorded in cellattached recordings (Fig. 5C ), LHb neurons were heterogeneous, frequently exhibiting phasic bursts of spontaneous action potentials followed by periods of inactivity (Fig. 5C ). Further, "anode break" excitation differed between MHb and LHb neurons: in whole-cell mode, MHb neurons exhibited single action potentials following a brief hyperpolarizing current injection (anode break action potentials; Fig. 5D ). In contrast, LHb neurons exhibited multiple lowamplitude anode break action potentials (Fig. 5D) . The latency to action potential firing during anode break was often, but not always, shorter in LHb cells versus MHb cells (Fig. 5D) .
Having established criteria to distinguish MHb from LHb neurons, we next recorded inward currents in response to nicotine in ChAT(ϩ) and ChAT(Ϫ) neurons. For both ChAT(ϩ) and ChAT(Ϫ) cells, we recorded robust responses to nicotine (30 M) (Fig. 5E ). Cells displaying nicotine-elicited inward currents were verified as ChAT(ϩ) or ChAT(Ϫ) by filling with neurobiotin, double-staining with streptavidin-Alexa-488 conjugate and anti-ChAT antibodies, and confocal imaging. Representative ChAT(ϩ) and ChAT(Ϫ) cells displaying nicotineelicited inward currents are shown (Fig.  5F ). These results suggest that nAChR function is not restricted to ChAT(ϩ) cells in MHbV. Neurons studied in subsequent recordings reported below were not analyzed for ChAT expression status.
Based on differences in localization of nAChR subunits within regions of MHbV (Fig. 3) , evidence for nAChRs in both ChAT(ϩ) and ChAT(Ϫ) cells (Fig. 5) , and emerging data showing specific gene expression in certain MHb to IPN circuits (Aizawa et al., 2012) , we focused on distinguishing neurons within the MHbV region. In particular, we recorded from MHbVL and MHbVC neurons (Fig. 6A ). In the cell-attached configuration, spontaneous action potential firing rates were similar in MHbVL and MHbVC neurons (MHbVL ϭ 4.3 Ϯ 0.5 Hz, MHbVC ϭ 5.0 Ϯ 0.6 Hz; unpaired t test, p ϭ 0.208). In whole-cell configuration, MHbVL and MHbVC neurons had a similar resting membrane potential when pipettes were filled with a K ϩ -gluconate-based internal pipette solution (MHbVL ϭ Ϫ42.2 Ϯ 1.7 mV, MHbVC ϭ Ϫ42.6 Ϯ 1.7 mV; unpaired t test, p ϭ 0.429). In a measure of cellular excitability, we measured spike amplitude after a prolonged (1000 ms), depolarizing (50 pA) current injection (i.e., adaptation ratio) (Fig. 6F ) (Bugaysen et al., 2010) . MHbVL neurons exhibited significantly more decline in spike amplitude after depolarizing current injection compared with MHbVC neurons (Fig. 6G) .
Tonic, spontaneous action potential firing (Fig. 5C ) suggested that MHbV neurons may express hyperpolarization-activated inward cation current (I h current). Both MHbVL and MHbVC neurons exhibited small but detectable I h current in response to hyperpolarization (Fig. 6B) , with MHbVC neurons exhibiting significantly more I h current than MHbVL neurons (Fig. 6C) . Differences in I h current in MHbVL and MHbVC neurons suggested that these cells may respond differentially after hyperpolarizing current pulses. To test this idea, MHbVL and MHbVC neurons in current-clamp mode were briefly (100 ms) injected with hyperpolarizing (Ϫ75 pA) current pulses, and the delay from the end of the pulse to the first action potential (i.e., rebound delay) was measured (Fig. 6D) . MHbVL neurons exhibited a significantly longer rebound delay compared with MHbVC neurons (Fig. 6E) , consistent with the idea that I h currents activated during the hyperpolarizing pulse help to depolarize the neuron, allowing it to reach threshold more quickly.
Next, we used linear regression analysis and tested whether two of the electrophysiological parameters we recorded were cor- related with expression of I h current. In both MHbVL and MHbVC neurons, I h current amplitude (at V m ϭ Ϫ120 mV) was anti-correlated with rebound delay (Fig. 6 H, J ) . Similarly, in both MHbVL and MHbVC neurons, I h current was positively correlated with adaptation ratio (Fig. 6 I, K ) (Bugaysen et al., 2010) . These results, in addition to revealing differences between MHbVL and MHbVC neurons, indicate that I h current may play a general role in shaping the excitability of MHbV neurons.
Based on differences in nAChR subunit localization between MHbVL and MHbVC neurons (Fig. 3) , and in part due to our results showing differences in excitability between these two regions of MHbV (Fig. 6) , we next studied nAChR function in MHbVL and MHbVC cells using puff-application of nicotine. MHbVL and MHbVC neurons were recorded in whole-cell configuration. Neurons were voltage-clamped at Ϫ60 mV and nicotine was puff-applied using a second drug-filled pipette positioned 20 -40 m from the recorded cell. Interestingly, MHbVL neurons exhibited small but detectable responses to 1 M nicotine (Fig. 7 A, B) . MHbVC neurons, on the other hand, did not respond appreciably to this concentration of nicotine (Fig.  7 A, B,D) . Both MHbVL and MHbVC neurons responded with inward currents following puff-application of 30 M nicotine, but mean responses in MHbVL neurons were, again, larger than in MHbVC neurons (Fig. 7C,D) .
Although nicotine typically achieves concentrations of 50 -200 nM in the CSF of smokers, concentrations of nicotine as high as 1 M have been reported as well (Malkawi et al., 2009) . Because nAChRs in MHbVL neurons are sensitive to 1 M nicotine, we tested the idea that MHbVL neurons would respond to prolonged (ϳ10 min) exposure to 1 M nicotine with altered action potential firing. Cell-attached recordings were made from MHbVL and MHbVC neurons, followed by bath application of 1 M nicotine. Whereas MHbVC neurons did not significantly change their firing in response to 1 M nicotine, MHbVL neurons exhibited a significant increase in firing rate relative to prenicotine baseline firing (Fig. 8 A, D,E) . Next, we sought to better understand the mechanism behind this difference in firing after nicotine application. Results from GFP-nAChR knock-in mice indicate that one defining factor of MHbVL neurons is their expression of ␣4 subunits (Fig. 3) . Because ␣4* nAChRs are among the most sensitive to nicotine and ACh (Salminen et al., 2004 (Salminen et al., , 2007 , we tested the idea that MHbVL sensitivity to 1 M nicotine (Fig. 8) required ␣4 subunits. We measured cell-attached firing in MHbVL neurons in slices from ␣4 knock-out mice, and we found that 1 M nicotine did not significantly increase firing above baseline levels (Fig. 8 B, D,E) . Next, because ␤4 subunit levels are strong in MHbVL (Fig. 3D) , we tested the hypothesis that ␤4 subunits play a role in the response to 1 M nicotine in MHbVL cells. Pretreatment of cells with SR16584, a selective antagonist of ␣3␤4* nAChRs, eliminated the increase in action potential firing rate elicited by 1 M nicotine in MHbVL neurons ( Fig. 8C-E) . Together, these results point to a role for ␣4 and ␤4 subunits, and likely nAChR pentamers containing both of these subunits, in the response of the MHb/IPN pathway to nicotine.
The MHb to IPN pathway is a key circuit mediating the somatic and affective signs of nicotine withdrawal in rodents, and presumably in humans. To determine whether MHbVL neurons play a role in nicotine withdrawal, we implanted C57BL/6 WT mice with osmotic minipumps delivering control saline or nicotine (1 mg/kg/h) for 14 d. To elicit withdrawal from nicotine, minipumps were removed, and brain slices were prepared for electrophysiology 18 -24 h later (Fig. 9A) . First, we measured nicotine-evoked currents using puff-application of 1 and 30 M nicotine. Compared with saline-withdrawn mice, there was a trend toward a decrease in nicotine-evoked currents in MHbVL neurons from nicotine-withdrawn mice at 1 M nicotine (Fig.  9 B, C) . Furthermore, there was a significant reduction in nicotine-evoked current amplitudes in nicotine-withdrawn MHbVL neurons at 30 M nicotine (Fig. 9 B, D) . Next, we measured action potential firing in response to nicotine (1 M) reexposure in MHbVL neurons from nicotine-and saline-withdrawn mice. Consistent with a reduction in nAChR responsiveness seen in puff-application experiments (Fig. 9D) , MHbVL neurons from nicotine-withdrawn mice exhibited a blunted response to nicotine application in cell-attached firing experiments (Fig. 9E) . Although raw baseline and nicotine-evoked firing rates in nicotine-and saline-withdrawn mice were similar (Fig. 9F) , nicotine-withdrawn MHbVL neurons did not respond to 1 M nicotine application with as large an increase in firing rate as salinewithdrawn MHbVL neurons (Fig. 9G) . To verify that our minipump procedure did indeed deliver chronic nicotine to mice, we conducted a control experiment. Mice implanted with saline-or nicotine-containing minipumps for 14 d were given an intraperitoneal injection of mecamylamine (1 mg/kg) to precipitate withdrawal from chronic nicotine, and mice were perfused 90 min later for immunohistochemical analysis. Coronal sections containing the IPN were stained for c-Fos induction, and we noted a large increase in c-Fos-immunoreactive neurons in the IPN of mecamylamine-injected mice treated with chronic nicotine versus mecamylamine-injected mice treated with chronic saline (Fig. 9H ) . This result parallels a recent result obtained by Tapper To further study MHbVL to IPN circuitry, we recorded from IPN neurons in the IPR and IPDM. These areas, according to our immunohistochemistry data (Fig. 4) , display high and specific expression of ␣4 nAChR subunits that largely originate in MHbVL. IPR/IPDM neurons were recorded in whole-cell configuration, first in current-clamp mode. Most IPR/IPDM neurons recorded from (19 of 25) did not fire spontaneously, and had an average resting membrane potential of Ϫ62 Ϯ 1 mV. Interestingly, when positive current was injected during current-clamp recordings, two responses were evident. One class of cells was less sensitive to current injection, responding to positive current injection with moderate increases in firing (Fig. 10A, left) . The other class of cells (Fig. 10A, right) was comparatively more sensitive to positive current injection and tended to exhibit rapid (Ͼ100 Hz) (Fig. 10D) , phasic bursts of action potentials (Fig.  10A, right) . For subsequent experiments (described below), we first recorded firing responses in current-clamp mode, and slower-firing and faster-firing neurons were classified as Type I and Type II IPR/IPDM neurons, respectively.
MHb neurons express cholinergic and glutamatergic markers, and in optogenetic experiments, appear to use both ACh and glutamate to signal to IPN neurons (Ren et al., 2011) . Thus, we reasoned that some IPN neurons likely express and use AMPAtype glutamate receptors (AMPARs). To study AMPARs, we puff-applied AMPA to IPR/IPDM neurons held in voltage-clamp mode similar to our previous study (Engle et al., 2013) . As with action potential firing, we found two types of responses to AMPA that cosegregated with action potential firing in response to positive current injection. Type I IPR/IPDM neurons exhibited responses to puffed AMPA (100 M) that were relatively small (Ϫ273.4 Ϯ 30 pA; Fig. 10B, left) , with a slower deactivation time constant of 16.7 Ϯ 3 s. By contrast, Type II IPR/IPDM neurons were found to have comparatively larger (Ϫ1292.0 Ϯ 116 pA; Fig. 10B , right) responses to AMPA with a much more rapid deactivation time constant of 5.7 Ϯ 1 s. To determine whether these differences in response to AMPA were due to greater potency of AMPA or greater efficacy of AMPA, we studied AMPA concentration-response relations for Type I and Type II IPR/IPDM neurons. The AMPA concentration-response data from Type I neurons were fitted (r 2 ϭ 0.60) to a monophasic function (Fig. 10E) , with an EC 50 of 30.5 M. Interestingly, AMPA concentration-response data from Type II neurons fit well (r 2 ϭ 0.87) to a biphasic function. The higher-sensitivity component had an EC 50 of 3.3 M, whereas the lower-sensitivity component had an EC 50 of 53.7 M. These differences in AMPAR function in Type I and Type II IPR/IPDM neurons suggest that AMPAR expression may be greater in Type II IPR/IPDM neurons or that different AMPAR subtypes are expressed in these two populations.
Our immunohistochemistry data (Fig. 4) suggest a prominent role for MHb-derived, presynaptic nAChRs in IPN. Our data do not, however, rule out a postsynaptic role for some nAChR subtypes in IPN. Several studies suggest a postsynaptic role for nAChRs in IPN (Wada et al., 1989; Hsu et al., 2013) . To study the action of nicotine on IPR/IPDM neurons and to further characterize Type I and Type II IPR/IPDM neurons, we studied responses to puffed nicotine. Like firing responses and AMPAevoked currents, nicotine-evoked currents exhibited a bimodal distribution: Type II neurons responded to 10 M nicotine with larger-amplitude currents compared with Type I neurons (Fig.  10C,F ) . This difference was also evident in responses to 1 M nicotine (Fig. 10F ) . Together, these recordings in two types of IPR/IPDM neurons reveal interesting differences between these cell types in excitability and coupling to glutamatergic and cholinergic afferents from MHbVL. . ␣3␤4* and/or ␣4* nAChRs drive nicotine-elicited firing in MHbVL neurons. A, Cell-attached recordings from MHbVL (n ϭ 8) and MHbVC (n ϭ 8) neurons were established, and baseline firing was recorded for several minutes, followed by superfusion of nicotine (1 M). Normalized firing rate is plotted, with baseline firing before nicotine application set to 1.0. B, Cell-attached recordings from ␣4 KO MHbVL neurons (n ϭ 9) were conducted. As in A, baseline firing was recorded followed by firing in response to superfusion of 1 M nicotine. Data from MHbVL WT neurons shown in A are replotted for reference using dashed lines and no symbols. C, Cell-attached recordings from WT MHbVL neurons (n ϭ 6) were conducted in response to SR16584, a putative ␣3␤4* nAChR antagonist. Baseline firing was recorded for several minutes, followed by superfusion of SR16584 (20 M), then superfusion of nicotine (1 M) plus SR16584. Data from MHbVL WT neurons shown in A (response to 1 M nicotine alone) are replotted for reference using dashed lines and no symbols. D, Representative traces from cell-attached firing experiments described in A-C. A sample current trace from t ϭ 2.5 min (baseline) and t ϭ 10 min (in 1 M nicotine) is shown for the indicated cell type, genotype, and/or pharmacological treatment. Calibration: 20 pA, 200 ms. E, Quantification of data shown in A-C. For each cell from each of 4 conditions described in A-C, the fold change in action potential firing was derived compared with predrug firing. A bar graph is shown for these 4 conditions. *p Ͻ 0.05 (paired t test comparing predrug firing and peak firing during drug application for each cell).
2001), possibly due to activation of nAChRs that do not strongly desensitize (Labarca et al., 2001) . ␣4␤4* nAChRs appear to show reduced desensitization compared with ␤2* nAChRs (Lax et al., 2002) , and in this study we have shown evidence for expression of this subtype in MHbVL neurons. nAChR-GFP mice will be useful in future experiments studying the relationship between nAChR activity and FR degeneration.
Surprisingly, nAChRs were not always seen within ChAT(ϩ) neurons. Anti-ChAT staining has been used as a marker for the MHbV (Fowler et al., 2011; Frahm et al., 2011; Ren et al., 2011) , and optogenetics experiments use the ChAT promoter to direct expression of channelrhodopsin and to therefore "control" MHbV activity (Ren et al., 2011; Hu et al., 2012) . Most neurons expressing ␣3, ␤3, and ␤4 subunits were ChAT-immunopositive, consistent with their role in regulating ACh release in IPN ). However, ␣6 and ␣4 subunits were often found in neurons that were ChAT(Ϫ). Future experiments will be required to determine what neurotransmitters these ChAT(Ϫ) neurons release and how nAChRs modulate their activity. Because recordings reported in Figures 6, 7 , 8, and 9 are from neurons whose ChAT expression status was not studied, data from these studies may represent a pool of both ChAT(ϩ) and ChAT(Ϫ) neurons.
nAChR function in MHbV neurons
Consistent with a previous (Kim and Chang, 2005) and a more recent (Görlich et al., 2013 ) report, we found that some MHb neurons exhibited spontaneous, tonic action potential firing in slice preparations. This tonic firing in MHb neurons is likely the result, at least in part, of expression of HCN channels and hyperpolarization-activated cation current (I h ) (Görlich et al., 2013) . Although I h current amplitudes in MHb neurons are smaller than those seen in SN pars compacta or VTA dopamine neurons (Engle et al., 2013) , our analysis suggests an important Figure 10 . IPR/IPDM neuron populations receiving input from MHbVL. A, IPR/IPDM neurons recorded in whole-cell configuration were held in current-clamp mode, and action potential firing was recording while the indicated amount of positive or negative current was injected. Based on the pattern of action potential firing, cells were classified as Type I or Type II. B, Type I or Type II IPR/IPDM neurons were voltage-clamped at Ϫ60 mV, and AMPA (100 M) was puff-applied. Representative traces are shown for each cell type. Calibration: 300 pA, 2 s. C, Type I or Type II IPR/IPDM neurons were voltage-clamped at Ϫ60 mV, and nicotine (10 M) was puff-applied. Representative traces are shown for each cell type. Calibration: 100 pA, 2 s. D, Quantification of action potential firing from A. Action potential firing after injection of the indicated amount of positive current was recorded, and the maximum instantaneous firing rate was derived and plotted for each current injection. The number of neurons analyzed was as follows: n ϭ 16 (Type I), n ϭ 9 (Type II). E, AMPA concentration response relation for Type I and Type II IPR/IPDM neurons. AMPA-evoked inward currents were recorded for a range of AMPA concentrations (in M: 1, 3, 10, 30, 100, and 300). Data from Type I neurons were fitted to a single-component function, whereas data from Type II neurons were fitted to a biphasic function. The number of Type I neurons analyzed for each AMPA concentration was as follows: n ϭ 3 (1 M), n ϭ 3 (3 M), n ϭ 7 (10 M), n ϭ 4 (30 M), n ϭ 16 (100 M), n ϭ 6 (300 M). The number of Type II neurons analyzed for each AMPA concentration was as follows: n ϭ 2 (1 M), n ϭ 2 (3 M), n ϭ 4 (10 M), n ϭ 3 (30 M), n ϭ 9 (100 M), n ϭ 3 (300 M). F, Quantification of nicotine-evoked currents in Type I and Type II IPR/IPDM neurons. Cells were voltage-clamped at Ϫ60 mV, nicotine (1 and 10 M) was puff-applied, and mean values are plotted. The number of Type I neurons analyzed for each nicotine concentration was as follows: n ϭ 7 (1 M), n ϭ 7 (10 M). The number of Type II neurons analyzed for each nicotine concentration was as follows: n ϭ 7 (1 M), n ϭ 7 (10 M). *p Ͻ 0.05 (unpaired t test).
role for I h in shaping MHb neuron excitability. This is supported by a recent report, which demonstrated that inhibition of MHb HCN channel activity can elicit behaviorally relevant changes in IPN activity (Görlich et al., 2013) . I h current amplitudes in individual cells were positively correlated with that cell's ability to fire sustained and high-frequency trains of action potentials, and I h current amplitude was negatively correlated with the latency to anode break firing (Fig. 6) . These data suggest that MHb provides a tonic glutamatergic and/or cholinergic signal to IPN neurons Ren et al., 2011; Hu et al., 2012) .
Surprisingly, neurons in MHbVL, but not MHbVC, were capable of responding to 1 M nicotine with responses similar in magnitude to those seen in rewardpathway VTA DA neurons at the same concentration of nicotine (Tapper et al., 2004; Drenan et al., 2008b) . Furthermore, 1 M nicotine also augmented MHbVL neuron action potential firing in a manner similar to that seen in VTA DA neurons (Liu et al., 2012) , and loss of ␣4 subunits eliminated this effect (Fig. 8) . MHbVC neurons, which are devoid of ␣4 subunits, did not express nAChRs that were sensitive enough to 1 M nicotine to elicit inward currents (Fig. 7) or action potential firing (Fig. 8) . Although SR16584 is generally considered a selective antagonist for ␣3␤4* nAChRs (Zaveri et al., 2010) , it has not been tested on ␣4␤4* nAChRs, whose subunits are found in MHbVL and respond well to 1 M nicotine (Luetje and Patrick, 1991; Puskar et al., 2011) . Our data also suggest that ␣3␤4* nAChRs play a role in the ability of MHbVL to respond to 1 M nicotine (Fig. 8) . Together, these recordings of action potential firing suggest at least two possibilities: (1) separable populations of ␣3␤4* and ␣4* nAChRs may mediate nicotine's action in accelerating MHbVL neuron firing; or (2) ␣3␣4␤4* receptors are at least partially responsible for the increase.
In contrast to ␣4␤2* nAChRs, ␣4␤4* nAChRs are not expected to undergo marked upregulation in response to chronic nicotine (Srinivasan et al., 2011) . In knock-in mice expressing YFP-labeled ␣4 subunits, ␣4 levels in MHb did not change significantly in response to chronic nicotine . Thus, if ␣4␤4* and/or ␣3␣4␤4* nAChRs are expressed at high levels in MHbVL neurons, it would account for the blunted response to nicotine in these cells from nicotinewithdrawn mice (Fig. 9) . A recent report corroborated our findings indicating that chronic nicotine reduces MHb neuronal excitability, although without determining which subregions of MHbV are involved (Dao et al., 2014) . Together, these data suggest that reexposure of MHbVL neurons to nicotine after nicotine withdrawal may result in reduced firing of these neurons and reduced glutamate and/or ACh release onto IPR/IPDM target neurons. If IPR/IPDM cells receiving innervation from MHbVL neurons are GABAergic, as suggested recently (Hsu et al., 2013; Zhao-Shea et al., 2013) , then reexposure to nicotine in nicotinewithdrawn animals could result in less activation of GABAergic IPR/IPDM neurons compared with nicotine exposure in control animals, which could ultimately contribute to relapse because of a reduction in aversive signals generated by the IPN (Fowler et al.,  2011) . Our withdrawal data highlight the importance of studying subregions of the MHb to IPN pathway, such as the MHbVL, as a recent study that did not restrict its analysis to specific MHbV areas found increased nicotine-evoked firing in neurons from nicotine-withdrawn mice (Görlich et al., 2013) . Further, we recently found increased ␣6 subunit levels in MHbVI of mice treated chronically with nicotine (Henderson et al., 2014) .
Our data reporting electrophysiologically distinct neuronal populations in IPR/IPDM (Fig. 10C ) are novel and build upon recently published data suggesting the existence of distinct cellular populations in IPN (Hsu et al., 2013; Zhao-Shea et al., 2013) . Compared with Type I IPR/IPDM neurons, Type II neurons may couple more strongly to cholinergic/glutamatergic input from MHbVL because of greater function of AMPA receptors (Fig.  10 B, E) and a stronger response to nicotine (Fig. 10C,F ) . Overall, these studies provide new anatomical and mechanistic details regarding nAChR expression and function in the brain's key aversion pathway.
